FPR1 and colorectal carcinoma: Circulating FPR was reported as a promising biomarker for diagnosis of CRC [10], and the two had better prognostic performances than the other inflammatory biomarkers for the localized non-small cell lung cancer and CRC, respectively [11, 14].